Similar articles

• Whole versus segmental pancreas graft: two years metabolic results.

  La Rocca E, Martin X, Secchi A, Lefrançois N, Martinenghi S, Melandri M, Touraine JL, Pozza G, Dubernard JM. La Rocca E, et al. Transplant Proc. 1990 Apr;22(2):653-4. Transplant Proc. 1990. PMID: 2183436 Clinical Trial. No abstract available.
• Long-term lipid metabolism in recipients of whole-organ pancreas transplants with normal glucose tolerance.

  Smith JL, Reynolds L, Corry RJ. Smith JL, et al. Transplant Proc. 1992 Jun;24(3):843-5. Transplant Proc. 1992. PMID: 1604635 Clinical Trial. No abstract available.
• Metabolic control at two months to 4.5 years after pancreatic transplantation, with special reference to the role of cyclosporine.

  Tydén G, Brattström C, Gunnarsson R, Lundgren G, Ost L, Ostman J, Groth CG. Tydén G, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):2294-6. Transplant Proc. 1987. PMID: 3274510 No abstract available.
• Metabolic control in recipients of duct-occluded segmental pancreatic grafts: a four-year follow-up.

  Holdaas H, Brekke IB, Hartmann A, Fauchald P, Berg KJ, Sødal G, Jervell J, Flatmark A. Holdaas H, et al. Transplant Proc. 1990 Apr;22(2):655-6. Transplant Proc. 1990. PMID: 2327010 No abstract available.
• A 10-year prospective study of IDDM patients subjected to combined pancreas and kidney transplantation or kidney transplantation alone.

  Tydén G, Bolinder J, Solders G, Nakache R, Brattström C, Tibell A, Groth CG. Tydén G, et al. Transplant Proc. 1997 Nov;29(7):3119. doi: 10.1016/s0041-1345(97)00805-1. Transplant Proc. 1997. PMID: 9365689 No abstract available.